MuRF1 Partners With TRIM72 to Impair Insulin Signaling in Skeletal Muscle Cells

Ibrahim Musa1,2, Alex Peter Seabright1, Jonathan Barlow1,3

  • 1School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, UK.

Insights

Muscle RING-finger protein 1 (MuRF1) interacts with TRIM72, impacting skeletal muscle atrophy and insulin sensitivity. This study reveals non-degradative roles for MuRF1 in muscle wasting and metabolic dysfunction.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • Muscle RING-finger protein 1 (MuRF1, TRIM63) is a key regulator of skeletal muscle atrophy.
  • The exact molecular mechanisms by which MuRF1 induces muscle atrophy are not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying MuRF1-mediated skeletal muscle atrophy.
  • To identify novel MuRF1 interaction partners and their roles in muscle physiology.

Main Methods:

  • Targeted biochemical approaches to identify MuRF1 interactors.
  • MuRF1 knockout and rescue experiments in C2C12 myotubes.
  • Dexamethasone treatment to induce atrophy markers.
  • Analysis of insulin signaling pathways (IRS1/Akt) and glucose uptake.

Main Results:

  • Tripartite motif-containing protein 72 (TRIM72) was identified as a novel MuRF1-interacting protein.
  • TRIM72 protein abundance is dependent on MuRF1 presence and increased by dexamethasone.
  • MuRF1 and TRIM72 cooperate to impair insulin signaling (IRS1/Akt) and glucose uptake, particularly in wild-type myotubes.

Conclusions:

  • MuRF1 plays non-degradative roles in skeletal muscle atrophy.
  • MuRF1, potentially through cooperation with TRIM72, contributes to impaired insulin sensitivity in muscle.
  • These findings link skeletal muscle atrophy and metabolic dysfunction at a molecular level.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.8K